Publication Results

Generate Report

Add publications by marking their checkboxes, or

Increased expression of PCGEM1 IncRNA in prostate cancer of African American men

Lee Jocelyn,  Jamal Muhammad,  Yan Wusheng,  Young Denise,  Song Yingjie,  Chen Yongmei,  Katta Shilpa,  Ravindranath Lakshmi,  Srinivasan Alagarsamy,  Cullen Jennifer,  Kagan Jacob,  Srivastava Sudhir,  Dobi Albert,  Rosner Inger L.,  McLeod David G.,  Sesterhenn Isabell A.,  Srivastava Shiv,  Petrovics Gyorgy
Cancer Res 2016 Mar 15;76
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma.

Wang M,  Devarajan K,  Singal AG,  Marrero JA,  Dai J,  Feng Z,  Rinaudo JA,  Srivastava S,  Evans A,  Hann HW,  Lai Y,  Yang H,  Block TM,  Mehta A
Cancer Prev Res (Phila) 2016 Feb;9(2):172-9
PubMed ID: 26712941
PMC ID: PMC4740237
Groups or Programs: Cancer Biomarkers

The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.

Wang H,  Shi T,  Qian WJ,  Liu T,  Kagan J,  Srivastava S,  Smith RD,  Rodland KD,  Camp DG 2nd
Expert Rev Proteomics 2016;13(1):99-114
PubMed ID: 26581546
PMC ID: PMC4822694
Groups or Programs: Cancer Biomarkers

Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.

Honda K,  Kobayashi M,  Okusaka T,  Rinaudo JA,  Huang Y,  Marsh T,  Sanada M,  Sasajima Y,  Nakamori S,  Shimahara M,  Ueno T,  Tsuchida A,  Sata N,  Ioka T,  Yasunami Y,  Kosuge T,  Miura N,  Kamita M,  Sakamoto T,  Shoji H,  Jung G,  Srivastava S,  Yamada T
Sci Rep 2015 Nov 9;5:15921
PubMed ID: 26549697
PMC ID: PMC4637825
Groups or Programs: Cancer Biomarkers

Advances in Biomedical Imaging, Bioengineering, and Related Technologies for the Development of Biomarkers of Pancreatic Disease: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases and National Institute of Biomedical Imaging and Bioengineering Workshop.

Kelly KA,  Hollingsworth MA,  Brand RE,  Liu CH,  Singh VK,  Srivastava S,  Wasan AD,  Yadav D,  Andersen DK
Pancreas 2015 Nov;44(8):1185-94
PubMed ID: 26465948
PMC ID: PMC4608388
Groups or Programs: Cancer Biomarkers

The Doylestown algorithm - a test to improve the performance of AFP in the detection of early stage hepatocellular carcinoma

Mehta Anand,  Wang Mengjun,  Devarajan Karthik,  Singal Amit G.,  Marrero Jorge A.,  Feng Ziding,  Rinaudo Jo Ann,  Srivastava Sudhir,  Evans Alison,  Hann Hie-Won,  Yang Hushan,  Javaid Asad,  Poongkuran Mugilan,  Lau Daryl,  Block Timothy
Hepatology 2015 Oct;62(Suppl 1):398A-398A
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

ERG-based stratification of prostate cancer highlights ethnicity associated biological differences

Dobi Albert,  Degon Michael,  Farrell James,  Baptiste Wagner,  Young Denise,  Chen Yongmei,  Petrovics Gyorgy,  Cullen Jennifer,  Kagan Jacob,  Srivastava Sudir,  Rosner Inger,  McLeod David G.,  Srivastava Shiv,  Sesterhenn Isabel
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 5277
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Analytical platform evaluation for quantification of ERG oncoprotein in prostate cancer using protein and mRNA detection methods

He Jintang,  Schepmoes Athena,  Rastogi Anshu,  Tan Shyh-Han,  Yan Wusheng,  Huang Wei,  Banerjee Sreedatta,  Shi Tujin,  Wu Chaochao,  Fillmore Thomas,  Gao Yuqian,  Kagan Jacob,  Srivastava Sudhir,  Smith Richard,  Qian Wei-Jun,  McLeod David,  Petrovics Gyorgy,  Dobi Albert,  Srinivasan Alagarsamy,  Srivastava Shiv,  Rodland Karin,  Liu Tao,  Camp David
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 1818
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Evaluation of prostate cancer biomarkers and therapeutic targets in FFPE specimens using the NanoString platform

Lee Jocelyn,  Yan Wusheng,  Young Denise,  Song Yingjie,  Chen Yongmei,  Katta Shilpa,  Mohamed Ahmed,  Ravindranath Lakshmi,  Srinivasan Alagarsamy,  Cullen Jennifer,  Kagan Jacob,  Srivastava Sudhir,  Dobi Albert,  Rosner Inger,  McLeod David G.,  Sesterhenn Isabell A.,  Srivastava Shiv,  Petrovics Gyorgy
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 2016
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Beneficial regulation of metabolic profiles by black raspberries in human colorectal cancer patients

Pan Pan,  Skaer Chad,  Stirdivant Steven,  Young Matthew R.,  Stoner Gary,  Lechner John,  Huang Yi-Wen,  Wang Li-Shu
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract LB-275
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

miRNA reference samples for interlaboratory study

Pine P. Scott,  Sorbara Lynn R.,  Srivastava Sudhir,  Salit Marc
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 3967
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Effects of black raspberry diet on the metabolomic profile of C57BL/6J mouse tissues

Skaer Chad W.,  Pan Pan,  Young Matthew,  Wang Hsin Tzu,  Oshima Kiyoko,  Huang Yi-Wen,  Stoner Gary D.,  Lechner John,  Wang Li-Shu
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract LB-263
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Early Detection Research Network (EDRN) validation of circulating ovarian cancer biomarkers

Skates Steven J.,  Anderson Karen S.,  Liu Tao,  Kulasingam Vathany,  Rabideau Dustin,  Wu Chaochao,  Gillette Michael,  Godwin Andrew K.,  Urban Nicole,  Lokshin Anna,  Marks Jeffrey,  Diamandis Eleftherios,  Zhang Zhen,  Srivastava Sudhir,  Kagan Jacob,  Patriotis Christos,  Rodland Karin
Cancer Res 2015 Aug 1;75(Suppl 15):Abstract 1570
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Beneficial Regulation of Metabolic Profiles by Black Raspberries in Human Colorectal Cancer Patients.

Pan P,  Skaer CW,  Stirdivant SM,  Young MR,  Stoner GD,  Lechner JF,  Huang YW,  Wang LS
Cancer Prev Res (Phila) 2015 Aug;8(8):743-50
PubMed ID: 26054356
PMC ID: PMC4527938
Groups or Programs: Cancer Biomarkers

Early detection of sporadic pancreatic cancer: summative review.

Chari ST,  Kelly K,  Hollingsworth MA,  Thayer SP,  Ahlquist DA,  Andersen DK,  Batra SK,  Brentnall TA,  Canto M,  Cleeter DF,  Firpo MA,  Gambhir SS,  Go VL,  Hines OJ,  Kenner BJ,  Klimstra DS,  Lerch MM,  Levy MJ,  Maitra A,  Mulvihill SJ,  Petersen GM,  Rhim AD,  Simeone DM,  Srivastava S,  Tanaka M,  Vinik AI,  Wong D
Pancreas 2015 Jul;44(5):693-712
PubMed ID: 25931254
PMC ID: PMC4467589
Groups or Programs: Cancer Biomarkers

A blinded multicenter phase II study of a panel of plasma biomarkers for the detection of triple negative breast cancer

Anderson Karen S.,  Pepe Margaret,  Marks Jeffrey,  Engstrom Paul,  Patriotis Christos,  Zangar Richard,  Skates Steven,  Lampe Paul,  LaBaer Joshua,  Li Christopher I.
Cancer Res 2015 May 1;75(9 Suppl):Abstract P4-05
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.

Schully SD,  Carrick DM,  Mechanic LE,  Srivastava S,  Anderson GL,  Baron JA,  Berg CD,  Cullen J,  Diamandis EP,  Doria-Rose VP,  Goddard KA,  Hankinson SE,  Kushi LH,  Larson EB,  McShane LM,  Schilsky RL,  Shak S,  Skates SJ,  Urban N,  Kramer BS,  Khoury MJ,  Ransohoff DF
J Natl Cancer Inst 2015 Apr;107(4)
PubMed ID: 25688116
PMC ID: PMC4342676
Groups or Programs: Cancer Biomarkers ;  Office of the Director

Racial/ethnic variation in a common genetic alteration in prostate cancer

Sesterhenn Isabell,  Young Denise,  Chen Yongmei,  Petrovics Gyorgy,  Cullen Jennifer,  Kagan Jacob,  Srivastava Sudhir,  Rosner Inger L.,  McLeod David G.,  Dobi Albert,  Srivastava Shiv
J Clin Oncol 2015 Mar 1;33(Suppl 7):Abstract 14
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.

He J,  Schepmoes AA,  Shi T,  Wu C,  Fillmore TL,  Gao Y,  Smith RD,  Qian WJ,  Rodland KD,  Liu T,  Camp DG 2nd,  Rastogi A,  Tan SH,  Yan W,  Mohamed AA,  Huang W,  Banerjee S,  Kagan J,  Srivastava S,  McLeod DG,  Srivastava S,  Petrovics G,  Dobi A,  Srinivasan A
J Transl Med 2015 Feb 12;13:54
PubMed ID: 25889691
PMC ID: PMC4342100
Groups or Programs: Cancer Biomarkers

Optimization of Nanostring Platform for Evaluation of Prostate Cancer Biomarkers and Therapeutic Targes in FFPE Specimens

Yan Wusheng,  Young Denise,  Song Yingjie,  Chen Yongmei,  Katta Shilpa,  Ravindranath Lakshmi,  Lee Jocelyn,  Srinivasan Alagarsamy,  Cullen Jennifer,  Kagan Jacob,  Srivastava Sudhir,  Dobi Albert,  Rosner Inger,  McLeod David,  Sesterhenn Isabell,  Srivastava Shiv,  Petrovics Gyorgy
Mod Pathol 2015 Feb;28(Suppl 2):268A-269A
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Optimization of Nanostring Platform for Evaluation of Prostate Cancer Biomarkers and Therapeutic Targes in FFPE Specimens

Yan Wusheng,  Young Denise,  Song Yingjie,  Chen Yongmei,  Katta Shilpa,  Ravindranath Lakshmi,  Lee Jocelyn,  Srinivasan Alagarsamy,  Cullen Jennifer,  Kagan Jacob,  Srivastava Sudhir,  Dobi Albert,  Rosner Inger,  McLeod David,  Sesterhenn Isabell,  Srivastava Shiv,  Petrovics Gyotgy
Lab Invest 2015 Feb;95(Suppl 1):268A-269A, Abstract 1070
PubMed ID: not available
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens.

Haab BB,  Huang Y,  Balasenthil S,  Partyka K,  Tang H,  Anderson M,  Allen P,  Sasson A,  Zeh H,  Kaul K,  Kletter D,  Ge S,  Bern M,  Kwon R,  Blasutig I,  Srivastava S,  Frazier ML,  Sen S,  Hollingsworth MA,  Rinaudo JA,  Killary AM,  Brand RE
PLoS One 2015;10(10):e0139049
PubMed ID: 26431551
PMC ID: PMC4592020
Groups or Programs: Cancer Biomarkers

Evaluation of two mitochondrial DNA biomarkers for prostate cancer detection.

Maragh S,  Veltri RW,  Lund SP,  Mangold L,  Isharwal S,  Christudass CS,  Partin AW,  Humphreys EB,  Sorbara L,  Srivastava S,  Wagner PD
Cancer Biomark 2015;15(6):763-73
PubMed ID: 26406418
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Generating a focused view of disease ontology cancer terms for pan-cancer data integration and analysis.

Wu TJ,  Schriml LM,  Chen QR,  Colbert M,  Crichton DJ,  Finney R,  Hu Y,  Kibbe WA,  Kincaid H,  Meerzaman D,  Mitraka E,  Pan Y,  Smith KM,  Srivastava S,  Ward S,  Yan C,  Mazumder R
Database (Oxford) 2015;2015:bav032
PubMed ID: 25841438
PMC ID: PMC4385274
Groups or Programs: Cancer Biomarkers

ERG monoclonal antibody in the diagnosis and biological stratification of prostate cancer: delineation of minimal epitope, critical residues for binding, and molecular basis of specificity.

Rastogi A,  Tan SH,  Banerjee S,  Sharad S,  Kagan J,  Srivastava S,  McLeod DG,  Srivastava S,  Srinivasan A
Monoclon Antib Immunodiagn Immunother 2014 Aug;33(4):201-8
PubMed ID: 25170998
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

Esserman LJ,  Thompson IM,  Reid B,  Nelson P,  Ransohoff DF,  Welch HG,  Hwang S,  Berry DA,  Kinzler KW,  Black WC,  Bissell M,  Parnes H,  Srivastava S
Lancet Oncol 2014 May;15(6):e234-42
PubMed ID: 24807866
PMC ID: PMC4322920
Groups or Programs: Cancer BiomarkersProstate and Urologic Cancer

A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum.

Shi T,  Gao Y,  Quek SI,  Fillmore TL,  Nicora CD,  Su D,  Zhao R,  Kagan J,  Srivastava S,  Rodland KD,  Liu T,  Smith RD,  Chan DW,  Camp DG 2nd,  Liu AY,  Qian WJ
J Proteome Res 2014 Feb 7;13(2):875-82
PubMed ID: 24251762
PMC ID: PMC3975687
Groups or Programs: Cancer Biomarkers

Brain order disorder 2nd group report of f-EE

Lalonde F,  Gogtay N,  Giedd J,  Vydelingum N,  Brown D,  Tran BQ,  Hsu C,  Hsu MK,  Cha J,  Jenkins J,  Ma L,  Willey J,  Wu J,  Oh K,  Landa L,  Lin CT,  Jung TP,  Makeig S,  Morabito CF,  Moon Q,  Yamakawa T,  Lee SY,  Lee JH,  Szu HH,  Kaur B,  Byrd K,  Dang K,  Krzywicki A,  Familoni BO,  Larson L,  Harkrider S,  Krapels KA,  Dai L
Conference Proceeding
2014
Groups or Programs: Cancer Biomarkers

Using Systems Biology to Understand Cancer as an Evolutionary Process

Pepper JW,  Dunn BK,  Fagerstrom RM,  Gohagan JK,  Vydelingum NA
Journal of Evolutionary Medicine 2014;2:1-8
PubMed ID: not available
PMC ID: not available
Groups or Programs: Chemopreventive Agent DevelopmentBiometryCancer Biomarkers

Neo-angiogenesis metabolic biomarker of tumor-genesis tracking by infrared joystick contact imaging in personalized homecare system

Szu HH,  Hoekstra PP,  Landa JS,  Vydelingum NA
Conference Proceeding
2014
Groups or Programs: Cancer Biomarkers

Long-gradient separations coupled with selected reaction monitoring for highly sensitive, large scale targeted protein quantification in a single analysis.

Shi T,  Fillmore TL,  Gao Y,  Zhao R,  He J,  Schepmoes AA,  Nicora CD,  Wu C,  Chambers JL,  Moore RJ,  Kagan J,  Srivastava S,  Liu AY,  Rodland KD,  Liu T,  Camp DG 2nd,  Smith RD,  Qian WJ
Anal Chem 2013 Oct 1;85(19):9196-203
PubMed ID: 24004026
PMC ID: PMC3839867
Groups or Programs: Cancer Biomarkers

The word "cancer": how language can corrupt thought.

Dunn BK,  Srivastava S,  Kramer BS
BMJ 2013 Sep 10;347:f5328
PubMed ID: 24022035
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Targeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletion.

Shi T,  Sun X,  Gao Y,  Fillmore TL,  Schepmoes AA,  Zhao R,  He J,  Moore RJ,  Kagan J,  Rodland KD,  Liu T,  Liu AY,  Smith RD,  Tang K,  Camp DG 2nd,  Qian WJ
J Proteome Res 2013 Jul 5;12(7):3353-61
PubMed ID: 23763644
PMC ID: PMC3733379
Groups or Programs: Cancer Biomarkers

The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator.

Ankerst DP,  Till C,  Boeck A,  Goodman P,  Tangen CM,  Feng Z,  Partin AW,  Chan DW,  Sokoll L,  Kagan J,  Wei JT,  Thompson IM
J Urol 2013 Jul;190(1):70-6
PubMed ID: 23313212
PMC ID: PMC3708069
Groups or Programs: Cancer Biomarkers ;  Community Clinical Oncology Program (CCOP) ;  Community Oncology and Prevention TrialsProstate and Urologic Cancer
Clinical Trials: Prostate Cancer Prevention Trial (PCPT)

Standards in molecular diagnostics for the discovery and validation of clinically useful cancer biomarkers.

Vydelingum NA,  Sorbara L,  Wagner P,  Srivastava S
Expert Rev Mol Diagn 2013 Jun;13(5):421-3
PubMed ID: 23782249
PMC ID: not available
Groups or Programs: Cancer Biomarkers

The Early Detection Research Network's Specimen reference sets: paving the way for rapid evaluation of potential biomarkers.

Feng Z,  Kagan J,  Pepe M,  Thornquist M,  Ann Rinaudo J,  Dahlgren J,  Krueger K,  Zheng Y,  Patriotis C,  Huang Y,  Sorbara L,  Thompson I,  Srivastava S
Clin Chem 2013 Jan;59(1):68-74
PubMed ID: 23193062
PMC ID: PMC3652317
Groups or Programs: Cancer Biomarkers

The early detection research network: 10-year outlook.

Srivastava S
Clin Chem 2013 Jan;59(1):60-7
PubMed ID: 23160065
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Agent-Based Models in Cancer Prevention Research.

Pepper JW,  Vydelingum NA,  Dunn BK,  Fagerstrom RM
2013
Kora AB
Advances in Computational Modeling Research
ISBN: 978-1-62618-065-9
Groups or Programs: BiometryCancer BiomarkersChemopreventive Agent Development

A simple packed bed device for antibody labelled rare cell capture from whole blood.

Kralj JG,  Arya C,  Tona A,  Forbes TP,  Munson MS,  Sorbara L,  Srivastava S,  Forry SP
Lab Chip 2012 Dec 7;12(23):4972-5
PubMed ID: 23079718
PMC ID: not available
Groups or Programs: Cancer Biomarkers

One hundred sixty-four consecutive beating heart totally endoscopic coronary artery bypass cases without intraoperative conversion.

Srivastava S,  Barrera R,  Quismundo S
Ann Thorac Surg 2012 Nov;94(5):1463-8
PubMed ID: 22771485
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Systematic, evidence-based discovery of biomarkers at the NCI.

Prensner JR,  Chinnaiyan AM,  Srivastava S
Clin Exp Metastasis 2012 Oct;29(7):645-52
PubMed ID: 22868876
PMC ID: PMC3679913
Groups or Programs: Cancer Biomarkers

Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests.

Liu T,  Hossain M,  Schepmoes AA,  Fillmore TL,  Sokoll LJ,  Kronewitter SR,  Izmirlian G,  Shi T,  Qian WJ,  Leach RJ,  Thompson IM,  Chan DW,  Smith RD,  Kagan J,  Srivastava S,  Rodland KD,  Camp DG 2nd
J Proteomics 2012 Aug 3;75(15):4747-57
PubMed ID: 22846433
PMC ID: PMC3410652
Groups or Programs: Cancer BiomarkersBiometry

A population approach to precision medicine.

Khoury MJ,  Gwinn ML,  Glasgow RE,  Kramer BS
Am J Prev Med 2012 Jun;42(6):639-45
PubMed ID: 22608383
PMC ID: PMC3629731
Groups or Programs: Cancer Biomarkers

Systematic, evidence-based discovery of biomarkers at the National Cancer Institute.

Srivastava S,  Patriotis C
Int J Gynecol Cancer 2012 May;22 Suppl 1:S41
PubMed ID: 22543920
PMC ID: not available
Groups or Programs: Cancer Biomarkers

New paradigms in translational science research in cancer biomarkers.

Wagner PD,  Srivastava S
Transl Res 2012 Apr;159(4):343-53
PubMed ID: 22424436
PMC ID: PMC3478674
Groups or Programs: Cancer Biomarkers

Updating risk prediction tools: a case study in prostate cancer.

Ankerst DP,  Koniarski T,  Liang Y,  Leach RJ,  Feng Z,  Sanda MG,  Partin AW,  Chan DW,  Kagan J,  Sokoll L,  Wei JT,  Thompson IM
Biom J 2012 Jan;54(1):127-42
PubMed ID: 22095849
PMC ID: PMC3715690
Groups or Programs: Cancer Biomarkers

Biomarkers in public health.

Srivastava S
Cancer Biomark 2012;10(1):1-2
PubMed ID: 22297546
PMC ID: not available
Groups or Programs: Cancer Biomarkers

Scientific frontiers: emerging technologies for salivary diagnostics.

Baum BJ,  Yates JR 3rd,  Srivastava S,  Wong DT,  Melvin JE
Adv Dent Res 2011 Oct;23(4):360-8
PubMed ID: 21917746
PMC ID: PMC3172997
Groups or Programs: Cancer Biomarkers

The human proteome project: current state and future direction.

Legrain P,  Aebersold R,  Archakov A,  Bairoch A,  Bala K,  Beretta L,  Bergeron J,  Borchers CH,  Corthals GL,  Costello CE,  Deutsch EW,  Domon B,  Hancock W,  He F,  Hochstrasser D,  Marko-Varga G,  Salekdeh GH,  Sechi S,  Snyder M,  Srivastava S,  Uhlén M,  Wu CH,  Yamamoto T,  Paik YK,  Omenn GS
Mol Cell Proteomics 2011 Jul;10(7):M111.009993
PubMed ID: 21742803
PMC ID: PMC3134076
Groups or Programs: Cancer Biomarkers

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.

Cramer DW,  Bast RC Jr,  Berg CD,  Diamandis EP,  Godwin AK,  Hartge P,  Lokshin AE,  Lu KH,  McIntosh MW,  Mor G,  Patriotis C,  Pinsky PF,  Thornquist MD,  Scholler N,  Skates SJ,  Sluss PM,  Srivastava S,  Ward DC,  Zhang Z,  Zhu CS,  Urban N
Cancer Prev Res (Phila) 2011 Mar;4(3):365-74
PubMed ID: 21372036
PMC ID: PMC3085251
Groups or Programs: Early DetectionCancer BiomarkersPLCO Cancer Screening Trial